Natural Killer T cells, 2012 Balancing the Regulation of Tumor Immunity Cancer Drug Discovery and Development Series
Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d+ and CD1d- tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index.
Date de parution : 10-2013
Ouvrage de 208 p.
15.5x23.5 cm
Date de parution : 09-2011
Ouvrage de 208 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 105,49 €
Ajouter au panierThèmes de Natural Killer T cells :
Mots-clés :
CD1d; dendric cells; iPS-Derived NKT Cells; lymphoma; α-Galactosylceramide